EARLY SYMPTOMATIC THERAPY WITH ALGINATES AND ANTACIDS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
A randomized clinical trial enrolling 86 patients with gastroesophageal reflux disease (GERD) has demonstrated the higher efficacy of an alginate than that of an aluminum and magnesium antacid in relieving the symptoms of GERD and dyspepsia.